Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Space Garden is a South Korean biotechnology company specializing in the development of plant-derived extracellular vesicles (EVs), commonly referred to as plant exosomes. The company leverages its proprietary isolation and stabilization technologies to harness the therapeutic potential of plant vesicles for applications in dermatology and regenerative medicine. Their primary focus areas include treatments for atopic dermatitis, hair loss, and skin barrier restoration. By utilizing plant-based sources, Space Garden aims to provide highly biocompatible and scalable alternatives to animal-derived or synthetic delivery systems. The company is currently in the pre-clinical stage, advancing its pipeline of exosome-based therapeutic candidates and high-performance cosmeceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Space Garden.